improving Oncology investigate with built-in KRAS Assay Services and RAS Assays
during the rapidly evolving discipline of oncology investigation, accurate and productive mutation screening is essential for developing qualified therapies. The KRAS solutions Platform plays a pivotal role During this landscape by offering complete remedies for KRAS mutation profiling and Assessment. KRAS mutations, located in approximately 95% of